This week's CotW includes the landscape of biomarkers and clinical trials for Alzheimer's disease. There is significant clustering around two biomarkers, but many interesting emerging biomarkers in clinical trials.
Purple: Clinical Trials
Yellow: FDA Cleared and Approved Tests
For a larger SVG version click here.
Share this Image On Your Site
For a refresher on Amplion and BiomarkerBase: